Search

everythinglearnresearchcommunity

for

Search:↓

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

Photodynamic therapy was effective in treating multiple scalp basal cell carcinomas with minimal side effects and good cosmetic results.

New treatments targeting the Hedgehog pathway can help treat advanced skin cancer but may have side effects and their effectiveness in early stages is unknown.

The study found that analyzing certain cell signaling pathways is not a reliable method to tell apart two types of skin tumors.

Basal cell carcinomas need extra mutations to grow from small to large tumors.

Basal cell epithelioma-like changes are most similar to normal basal cells.

CK 15, follistatin, and Bmi-1 can help differentiate basal cell carcinoma from squamous cell carcinoma.

Sonidegib effectively treated advanced basal cell carcinoma with mild side effects.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

Damaged hair follicles make mice more prone to skin inflammation and skin cancer after UV exposure.

BKN-1 antibody targets specific keratin in basal cell epithelioma and normal skin basal cells.

Basal cell carcinoma shows keratin patterns similar to hair follicle structures.

BerEP4 and CD34 staining can help tell apart tricholemmoma from basal cell carcinoma.

Scalp basal cell carcinoma in Asians is different from facial basal cell carcinoma, with unique features like being more common in younger people and having larger tumors.

Basal stem cells in the skin have distinct types that are crucial for skin structure and health.

The research suggests new treatments for skin cancer could target specific cell growth pathways.

Basal cell carcinomas may differentiate similarly to hair follicles and could be influenced by hair cycle-related treatments.

Recognizing rare tumor combinations is crucial for accurate diagnosis and treatment.

Dr. Connelly agrees that linear basal cell carcinomas might be more aggressive but highlights the study's lack of clear criteria to identify them.

The review found that basal cell carcinomas on the scalp are not more aggressive than those in other locations.

Nevoid basal cell carcinomas start in the skin's top layer and hair follicles.

The research created a detailed map of skin cells, showing that certain cells in basal cell carcinoma may come from hair follicles and could help the cancer grow.

The research created a detailed map of skin cells, showing that certain cells in basal cell carcinoma may come from hair follicles and could help the cancer grow.

Heat shock proteins help basal cell carcinoma grow by responding to inflammation signals.

External factors can cause skin cancer cells that usually don't spread to grow and form tumors in mice.

Different tumor cells in one basal cell carcinoma can cause mixed treatment responses, suggesting personalized treatment is needed.

Looking at tissue characteristics isn't reliable for telling apart basal cell carcinoma from certain benign skin tumors.

The antibody created from BCC tissues reacts similarly to both BCC and hair follicles, suggesting BCC may come from hair follicle cells.

Sonidegib is effective and safe for treating advanced basal cell carcinoma, but biopsies are needed to confirm tumor clearance.

CD34 is absent in most basal cell carcinoma cells but present in surrounding skin.